FDA Inspection 1071677 — Frontage Clinical Services, Inc.

Frontage Clinical Services, Inc. — FEI 3005134380

The FDA completed an inspection of Frontage Clinical Services, Inc. on Oct 19, 2018 in Secaucus, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 19, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Secaucus, NJ (United States)

Additional details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.